Do Acetylcholinesterase Inhibitors Have a Role in Improving Cognitive Impairment in Patients with Schizophrenia?

Author： Alessandro Lenzi Daniela Tuscano

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.18, Iss.3, 2004-01, pp. : 139-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Do QOL scores reflect therapy in schizophrenia?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 310, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Treatment of Cognitive Impairment in Multiple Sclerosis: Is the Use of Acetylcholinesterase Inhibitors a Viable Option?

By Christodoulou Christopher

CNS Drugs, Vol. 22, Iss. 2, 2008-01 ,pp. : 87-97

Adis International

Access to resources Recommend Favorite

Bifeprunox: beneficial in schizophrenia?

Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Predictor of treatment response in schizophrenia?

Inpharma, Vol. 1, Iss. 1280, 2001-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Atypical antipsychotics cause diabetes mellitus in schizophrenia?

Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite